Picture of Ginkgo Bioworks Holdings logo

DNA Ginkgo Bioworks Holdings Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapSucker Stock

Momentum

Relative Strength (%)
1m-19.39%
3m-44.22%
6m-49.9%
1yr-34%
Volume Change (%)
10d/3m-1.43%
Price vs... (%)
52w High-57.96%
50d MA-16.07%
200d MA-34.69%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-60.4%
Return on Equity-63.02%
Operating Margin-360.66%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Ginkgo Bioworks Holdings EPS forecast chart

Profile Summary

Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. It operates through two segments: Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatic testing products and services primarily provided to public health authorities. It offers Concentric, which is a global infrastructure for biosecurity to prevent, detect and respond to a wide variety of biological threats. The Company is also engaged in building and deploying machine learning models to solve impactful problems in biology.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    September 15th, 2021
    Public Since
    April 19th, 2021
    No. of Shareholders
    721
    No. of Employees
    1,218
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    us flag iconNew York Stock Exchange
    Shares in Issue
    2,152,395,786

    DNA Share Price Performance

    Upcoming Events for DNA

    Ginkgo Bioworks Holdings Inc Annual Shareholders Meeting

    Similar to DNA

    Picture of ADC Therapeutics SA logo

    ADC Therapeutics SA

    us flag iconNew York Stock Exchange

    Picture of Alto Neuroscience logo

    Alto Neuroscience

    us flag iconNew York Stock Exchange

    Picture of Annovis Bio logo

    Annovis Bio

    us flag iconNew York Stock Exchange

    Picture of Arcus Biosciences logo

    Arcus Biosciences

    us flag iconNew York Stock Exchange

    Picture of Biohaven logo

    Biohaven

    us flag iconNew York Stock Exchange

    FAQ